| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | MilliporeSigma Invests €62M in Quality Control Facility in Germany | ||
| Di | Siegfried to Acquire Early-Phase CDMO in Wisconsin | ||
| Di | Ascidian Therapeutics, Roche Enter Research Collaboration & License Agreement | ||
| Di | Merck Receives FDA Approval for CAPVAXIVE | ||
| Di | Cresset Completes SOC 2 Type 1 Audit | ||
| Di | EUROAPI, Priothera Enter CDMO Collaboration | ||
| Di | Medidata Introduces Clinical Data Studio | ||
| Di | Thermo Fisher Adds New Clinical Research Lab at Wisconsin Site | ||
| Di | MilliporeSigma Contributes to Advancing Parkinson's Research | ||
| Di | Iambic Therapeutics Closes Oversubscribed $50M Series B Extension | ||
| Mo | ChemWerth Names New CEO | ||
| Mo | RevOpsis, Kemwell Enter Manufacturing Partnership to Accelerate Development of RO-104 | ||
| Mo | EUROAPI Reaches Major Health IPCEI Milestone | ||
| Mo | DHL Supply Chain Expands Pharma Logistics Operations in France | ||
| Mo | Actylis Names Scott Thomson as CEO | ||
| Mo | Charles River, Captain T Cell Sign Plasmid DNA & Viral Vector Production Program Agreement | ||
| Mo | Freeline Therapeutics Rebrands to Spur Therapeutics | ||
| Fr | Wacker Opens mRNA Competence Center in Germany | ||
| Fr | Takeda, Ascentage Pharma Sign Option Agreement | ||
| Fr | Lotte Biologics and Merck KGaA Ink Biomanufacturing and Process Development Partnership | ||
| Fr | Enveda Biosciences Announces New $55M Financing Round | ||
| Fr | Santa Ana Bio Emerges from Stealth with $168M in Funding | ||
| Do | Bio-Sourcing and Afrigen Biologics Partner on Biomanufacturing Platform | ||
| Do | CDMO BioCina Partners with CelluTx | ||
| Do | Rocketvax Collaborates with NIH for Clinical Trial of RVX-sCPD9 Candidate |